- Report
- May 2019
- 835 Pages
Global
From €8211EUR$8,500USD£7,021GBP
- Report
- August 2023
Japan, United States, ... Japan, United States, Europe
From €1449EUR$1,500USD£1,239GBP
- Report
- April 2022
Japan, United States, ... Japan, United States, Europe, Global
From €2656EUR$2,750USD£2,271GBP
- Report
- December 2021
Global
From €4685EUR$4,850USD£4,006GBP
- Report
- February 2020
- 205 Pages
Japan, United States, ... Japan, United States, Europe, Global
From €4347EUR$4,500USD£3,717GBP
- Report
- July 2019
- 835 Pages
Global
From €8211EUR$8,500USD£7,021GBP
From €918EUR$950USD£785GBP
The Streptococci Test market is a segment of the Point-of-Care Diagnostics industry. It is focused on the development and commercialization of tests that detect the presence of Streptococcus bacteria. These tests are used to diagnose a variety of infections, including strep throat, pneumonia, and meningitis. The tests are typically performed in a doctor's office or clinic, and the results are available quickly.
The Streptococci Test market is highly competitive, with a number of companies offering products. These include Abbott, Becton Dickinson, Cepheid, DiaSorin, and Quidel. Each company offers a range of tests, with varying levels of accuracy and sensitivity. Additionally, some companies offer tests that are designed to detect multiple types of Streptococcus bacteria. Show Less Read more